Jesse L. Goodman

Trustee at U.S. Pharmacopeial Convention

Having served as President of the USP Convention during the 2015-2020 cycle, Dr. Jesse Goodman will help guide USP as it begins its third century of promoting and protecting public health. In his role as Medical Sciences Trustee on USP’s board, Dr. Goodman will apply his knowledge of USP along with his personal and professional experience as the organization rises to the challenges of the global supply chain and helping to ensure ongoing access to quality medicines for people around the world.

His day-to-day experiences as a practicing clinician coupled with the knowledge that he gained during years with FDA have given Dr. Goodman an appreciation for the need for balanced and collaborative approaches to regulations and what that could do to keep the drug and food supply as safe and effective as possible.

Dr. Goodman is the Director of the Center on Medical Product Access, Safety and Stewardship and attending physician at Georgetown University and DC Veterans Administration Hospitals. Until 2014, Dr. Goodman was FDA’s Chief Scientist, leading crosscutting scientific efforts, including public health preparedness and medical countermeasures. Prior to that, Dr. Goodman directed FDA’s Center for Biologics Evaluation and Research, supporting innovative regulatory approaches to vaccines and other biologics and spearheading unique public–private efforts to address public health challenges. As Senior Advisor to the Commissioner, he initiated the first U.S. Task Force on Antimicrobial Resistance. Having served on the World Health Organization’s Ebola Vaccine Working Group, Dr. Goodman helped develop the Global Vaccine Action Plan. He is currently on the Centers for Disease Control and Prevention’s Board of Scientific Counselors (Infectious Diseases).

A Harvard graduate, Dr. Goodman received his M.D. from Albert Einstein College of Medicine and completed postdoctoral training at the University of Pennsylvania and UCLA, where he was Chief Resident. He has been elected to the Institute of Medicine of the National Academy of Sciences.

Timeline

  • Trustee

    Current role